) recently announced that its chairman and board member, Harold
T. Shapiro will soon retire from the board of directors.
Shapiro will not contest for re-election at the annual
shareholders' meeting to be held on Nov 6. He will be replaced by
Dr. Connie Curran who has been a director at DeVry since Nov
2003. Dr. Curran's appointment as the board's chairman and
Shapiro's retirement will be effective at the annual meeting.
With Shapiro's retirement the board will be left with only 11
Dr. Curran's substantial experience in the field of healthcare
and healthcare consulting goes in sync with DeVry's increasing
focus on healthcare education.
Last week, DeVry announced its intention to buy a privately
held Brazilian healthcare education company, Faculdade
Differential Integral (Facid), for an undisclosed amount. Facid,
which operates through its two campuses in the city of Teresina,
offers primarily healthcare degrees including a Doctor of
Medicine (M.D.) program. It also offers undergraduate degrees in
other healthcare fields such as nursing, pharmacy and dentistry,
as well as a law program.
Healthcare has, of late, become a highly sought-after field of
education. DeVry's other medical institutions like Chamberlain
College of Nursing and Carrington Colleges are currently doing
well gaining from higher demand for medical doctors and
veterinarians. Enrollment growth at these colleges is also
improving due to higher quality enquiries and conversion rates,
resulting from improved recruitment efforts and new branding
initiatives by DeVry.
DeVry carries a Zacks Rank #3 (Hold). Other stocks in the
education industry that are currently performing well and have a
bright outlook include
New Oriental Education & Technology Group
), carrying a Zacks Rank #1(Strong Buy) and
Xueda Education Group
Grand Canyon Education, Inc.
), both carrying a Zacks Rank #2 (Buy).
CHINAEDU CP-ADR (CEDU): Free Stock Analysis
DEVRY INC (DV): Free Stock Analysis Report
NEW ORIENTAL ED (EDU): Free Stock Analysis
GRAND CANYON ED (LOPE): Free Stock Analysis
To read this article on Zacks.com click here.